Skip to search.
 TSX Up 0.00% TSX Ventures Up 0.58%

Biogen Inc. (BIIB)

-NasdaqGS
264.62 May 5, 4:00PM EDT
Prev Close:264.62
Open:N/A
Bid:261.31 x 200
Ask:267.33 x 200
1y Target Est:345.50
Beta:0.3261
Earnings Date:Jul 22 - Jul 26 (Est.)
Day's Range:N/A - N/A
52wk Range:242.07 - 420.99
Volume:0
Avg Vol (3m):1,755,030
Market Cap:57.97B
P/E (ttm):17.25
EPS (ttm):15.34
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
BIIB 0.00%57.97B
PFE207.86B
ABT56.58B

Key Statistics

Forward P/E (1 yr):13.18
P/S (ttm):5.38
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-16) :18.83
Quarterly EPS Est (Jun-16) :4.66
Mean Recommendation*:2.1
PEG Ratio (5 yr expected):1.48

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Biogen Inc. discovers, develops, manufactures, and delivers therapies for the treatment of neurodegenerative diseases, hematologic conditions, and autoimmune disorders. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback